Abrishami, M.A. and Thomas, J.: Aspirin intolerance — A review. Annals of Allergy 39: 28–37 (1977).
Ali, M.A. and Routh, J.I.: The protein binding of acetylsalicylic acid and salicylic acid, Clinical Chemistry 15: 1027–1038 (1969).
Ali Laik, S.: A comparative study of the derivatization of salicylic acid and acetylsalicylic acid with BSTFA, MSTFA and methyl rodide in presence of potassium carbonate prior to GLC determination. Chromatografia 8: 33–34 (1975).
Ali, M.; McDonald, J.W.; Thiessen, J.J. and Coates, P.E.: Plasma acelylsalicylate and salicylate and platelet cyclooxygenase activity following plain and enteric-coated aspirin, Stroke 11: 9–13 (1980).
American Pharmaceutical Association: Evaluations of Drug Interactions, 2nd. ed, (APA, Washington, 1976).
Ascione, P.P. and Chrekian, G.P.: Automated high-pressure liquid chromatographic analysis of aspirin, phenacetin, and caffeine. Journal of Pharmaceutical Sciences 64: 1029–1033 (1979).
Athreya, B.H.; Moser, G.; Cecil, H.S. and Myers, A.R.: Aspirin-induced hepatotoxicity in juvenile rheumatoid arthritis, A prospective study. Arthritis and Rheumatism 18: 347–352 (1975).
Bardare, M.; Chislaghi, G.U.; Mandelli, M. and Sereni, F.: Value of monitoring plasma salicylate levels in treating juvenile rheumatoid arthritis: observations in 42 cases. Archives of Disease in Childhood 53: 381–385 (1978).
Bedford, C.; Cummings, A.J. and Martin, B.K.: A kinetic study of the elimination of salicylate in man. British Journal of Pharmacology 24: 418–431 (1965).
Bender, K.J.: Salicylate intoxication. Drug Intelligence and Clinical Pharmacy 9: 350–360 (1975).
Berg, K.J.: Acute acetylsalicylic acid poisoning: Treatment with forced alkaline diuresis and diuretics. European Journal of Clinical Pharmacology 12: 111–116 (1977a).
Berg, K.J.: Acute effects of acetylsalicylic acid in patients with chronic renal insufficiency. European Journal of Clinical Pharmacology 11: 111–116 (1977b).
Berg, K.J.: Acute effects of acetylsalicylic acid on renal function in normal man. European Journal of Clinical Pharmacology 11: 117–123 (1977c).
Bernstein, B.H.; Singsen, B.H.; King, K.K. and Hanson, V.: Aspirin-induced hepatotoxicity and its effect on juvenile rheumatoid arthritis. American Journal of Diseases of Children 131: 659–663 (1977).
Bernstein, S.H. and Allerhand, J.: Abnormalities or serum proteins as criteria for the diagnosis of acute rheumatic fever. American Journal of Medical Sciences 247: 431–437 (1964).
Blair, D.; Rumack, B.H. and Peterson, R.G.: Analysis for salicylic acid in serum by high-performance liquid chromatography. Clinical Chemistry 24: 1543–1544 (1978).
Borga, O.; Odar-Cederlöf, I.; Ringberger, V.-A. and Norlin, A.: Protein binding of salicylate in uremic and normal plasma. Clinical Pharmacology and Therapeutics 20: 464–475 (1976).
Brown, S.S.; Cameron, J.C. and Matthew, H.: Plasma salicylate levels in acute poisoning in adults. British Medical Journal 2: 738–739 (1967).
Buchanan, N. and Rabinowitz, L.: Infantile salicylism — A reappraisal. Journal of Pediatrics 84: 391–395 (1974).
Calabro, J.J.; Burnstein, S.L. and Staley, H.L.: Letter to the Editor. Scandinavian Journal of Rheumatology 5: 251–252 (1976).
Cassell, S.; Furst, D.; Dromgoole, S. and Paulus, H.: Steady-state serum salicylate levels in hospitalized patients with rheumatoid arthritis. Arthritis and Rheumatism 22: 384–388 (1979).
Chiou, W. and Onyemelukwe, I.: Disintegration, dissolution and oral absorption in humans of five commercial buffered aspirin dosage form. Journal of Clinical Pharmacology 14: 597–603 (1974).
Coldwell, B.B.; Solomonraj, G.; Boyd, E.M.; Jante, J. and Morrison, A.B.: The effect of dosage from and route of administration on the absorption and excretion of acetylsalicylic acid in man. Clinical Toxicology 2: 111–127 (1969).
Craig, J.O.; Ferguson, I.C. and Syme, J.: Infants, toddlers and aspirin. British Medical Journal 1: 757–761 (1966).
Cummings, A.J.; Martin, B.K. and Renton, R.: The elimination of salicylic acid in man: serum concentrations and urinary excretion rates. British Journal of Pharmacology 26: 461–467 (1966).
Davies, M.G.; Vella Briffa, D. and Greaves, M.W.: Systemic toxicity from topically applied salicylic acid. British Medical Journal 1: 661 (1979).
Davison, C.: Salicylate metabolism in man. Annals of the New York Academy of Sciences 179: 249–268 (1971).
Davison, C. and Mandel, H.G.: Nonnarcotic analgesics and antipyretics, 1. Salicylates; in Di Palma (Ed.) Drill’s Pharmacology in Medicine, pp. 379–403 (McGraw-Hill, New York 1971).
Davison, C. and Smith, P.K.: The binding of salicylic acid and related substances to purified proteins. Journal of Pharmacology and Experimental Therapeutics 133: 161–170 (1961).
Day, R.; Shen, D. and Azarnoff, D.: Decline of steady-state serum salicylate in rheumatoid arthritis given high-dosage salicylate therapy. Clinical Pharmacology and Therapeutics 25: 220–221 (1979).
Dick, W.C.; Gibson, R.; Gray, G.I.L. and Buchanan, W.W.: Salicylates and homeopathy. British Journal of Clinical Pharmacology 7: 530–531 (1979).
Done, A.K.: Significance of measurements of salicylate in blood in case of acute ingestion. Pediatrics 26: 800–807 (1960).
Done, A.K.: Salicylate, pharmacokinetics, and the Pediatrician. Pediatrics 54: 670–672 (1974).
Doughty, R.A.; Gresecke, L. and Athreya, B.: Prospective study of salicylate therapy in juvenile rheumatoid arthritis. Dosage-serum salicylate levels and clinical/biochemical toxicity. Clinical Pharmacology and Therapeutics 25: 221 (1979).
Edwards, L.J.: Dissolution and diffusion of aspirin in aqueous media. Trans Faraday Society 47: 1191–1210 (1951).
Ekstrand, R.; Alvan, G. and Borgå, O.: Concentration dependent plasma protein binding of salicylate in rheumatoid patients. Clinical Pharmacokinetics 4: 137–143 (1979).
Elliott, H.C.: Urinary excretion kinetics of salicyluric acid. Proceedings of the Society for Experimental Biology and Medicine 121: 861–864 (1966).
Furst, D.E.; Gupta, N. and Paulus, H.E.: Evidence suggesting a genetic influence and induction of salicylurate formation. Journal of Clinical Investigation 60: 32–42 (1977).
Gibaldi, M.; Grundhofer, B. and Levy, G.: Time course and dose dependence of antacid effect on urine pH. Journal of Pharmaceutical Sciences 64: 2003–2004 (1975).
Gibson, T.; Zaphiropoulos, G.; Grove, J.; Widdop, B. and Berry, D.: Kinetics of salicylate metabolism. British Journal of Clinical Pharmacology 2: 233–238 (1975).
Gibson, R.G.; Gibson, S.L.M.; MacNeill, A.D.; Gray, G.H.; Dick, W.C. and Buchanan, W.W.: Salicylates and homeopathy in rheumatoid arthritis: preliminary observations. British Journal of Clinical Pharmacology 6: 391–395 (1978).
Graham, G.G.; Champion, G.D.; Day, R.O. and Pauli, P.D.: Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis. Clinical Pharmacology and Therapeutics 22: 410–420 (1977).
Gunsberg, M.; Cham, B.E.; Imhoff, D.M.; Parsons, G.; Bochner, F. and Johnson, F.L.: Correlation of aspirin dose with concentrations of salicylic acid in plasma, plasma water and saliva and clinical response in patients with rheumatoid disease. Australian and New Zealand Journal of Medicine 10: 268–278 (1980).
Gupta, N.; Sarkissian, E. and Paulus, H.E.: Correlation of plateau serum salicylate level with rate of salicylate metabolism. Clinical Pharmacology and Therapeutics 18: 350–355 (1975).
Harris, P.A. and Riegelman, S.: Acetylsalicylic acid hydrolysis in human blood and plasma. I. Methodology and in vitro studies. Journal of Pharmaceutical Sciences 56: 713–716 (1967).
Hill, J.B.: The effect of altering blood pH on rat tissue and plasma salicylate concentrations. Federation Proceedings 29: 434 proc. (1970).
Hill, J.B.: Salicylate intoxication. New England Journal of Medicine 288: 1110–1113 (1973).
Hill, J.B. and Smith, R.M.: An automated microfluoromatic determination after salicylate in body fluids and tissue extracts. Biochemical Medicine 4: 24–35 (1970).
Hollister, L. and Levy, G.: Some aspects of salicylate distribution and metabolism in man. Journal of Pharmaceutical Sciences 54: 1126–1129 (1965).
Huston, G.: Salicylates and homeopathy. British Journal of Clinical Pharmacology 7: 529–530 (1979).
Jick, H. and Porter, J.: Drug-induced gastrointestinal bleeding. Lancet 2: 87–89 (1978).
Klinenberg, J.R. and Miller, F.: Effect of corticosteroids on blood salicylate concentration. Journal of the American Medical Association 194: 601–604 (1965).
Kramer, E, and Routh, J.I.: The binding of salicylic acid and acetylsalicylic acid to human serum albumin. Clinical Biochemistry 6: 98–105 (1973).
Kucera, J.L. and Bullock, F.J.: The binding of salicylate to plasma protein from several animal species. Journal of Pharmacy and Pharmacology 21: 293–296 (1969).
Lainhaw, D.A.: Rheumatoid arthritis improved by treatment with levamisole and L-histoline. Medical Journal of Australia 2: 382–385 (1976).
Leonards, J.R.: The influence of solubility on the rate of gastrointestinal absorption of aspirin. Clinical Pharmacology and Therapeutics 4: 476–479 (1963).
Leonards, J.R. and Levy, C.: Absorption and metabolism of aspirin administered in enteric coated tablets. Journal of American Medical Association 193: 99–104 (1965).
Levy, G.: Salicylurate formation — demonstration of Michaelis-Menten kinetics in man. Journal of Pharmaceutical Sciences 54: 496 (1965a).
Levy, G.: Comparison of dissolution and absorption rates of different commercial aspirin tablets. Journal of Pharmaceutical Sciences 50: 388–392 (1961).
Levy, G.: Effect of certain tablet formulation factors on dissolution rate of the active ingredient. I. Journal of Pharmaceutical Sciences 52: 1039–1046 (1963).
Levy, G.: Pharmacokinetics of salicylate elimination in man. Journal of Pharmaceutical Sciences 54: 959–967 (1965b).
Levy, G. and Garrettson, L.K.: Kinetics of salicylate elimination by newborn infants of mothers who ingested aspirin before delivery. Pediatrics 53: 201–210 (1974).
Levy, G. and Giacomini, K.M.: Rational aspirin dosage regimens. Clinical Pharmacology and Therapeutics 23, 247–252 (1978).
Levy, G. and Gumlow, R.H.: Effect of certain tablet formulation factors on dissolution rate of active ingredients. III. Tablet lubricants. Journal of Pharmaceutical Sciences 52: 1139–1144 (1963).
Levy, G. and Hollister, L.E.: Inter- and intrasubject variations in drug absorption kinetics. Journal of Pharmaceutical Sciences 53: 1446–1452 (1964).
Levy, G. and Leonards, J.R.: Absorption, metabolism and excretion of salicylates: in Smith and Smith (Eds.) The Salicylates: A critical bibliographic review. pp.5–48 (Interscience, New York 1966).
Levy, G. and Tsuchiya, T.: Salicylate accumulation kinetics in man. New England Journal of Medicine 287: 430–432 (1972).
Levy, G. and Tsuchiya, T.: Effect of activated charcoal on aspirin absorption in man. I. Clinical Pharmacology and Therapeutics 13: 317–322 (1972b).
Levy, G. and Yaffe, S.J.: The study of salicylate pharmacokinetics in intoxicated infants and children. Clinical Toxicology 1: 409–424 (1968).
Levy, G. and Yaffe, S.J.: Relationship between dose and apparent volume of distribution of salicylate in children. Pediatrics 54: 713–717 (1974).
Levy, G.; Amsel, L.P. and Elliott, H.C.: Kinetics of salicyluric acid elimination in man. Journal of Pharmaceutical Sciences 58: 827–829 (1969a).
Levy, G.; Procknal, J.A. and Garrettson, L.K.: Distribution of salicylate between neonatal and maternal serum at diffusion equilibrium. Clinical Pharmacology and Therapeutics 18: 210–214 (1975a).
Levy, O.; Vogel, A.W. and Amsel, L.P.: Capacity-limited salicylurate formation during prolonged administration of aspirin to healthy human subjects. Journal of Pharmaceutical Sciences 58: 503–504 (1969b).
Levy, G.; Tsuchiya, T. and Amsel, L.P.: Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man. Clinical Pharmacology and Therapeutics 13: 258–268 (1972).
Levy, G.; Lampman, T.; Kamath, B.L. and Garrettson, L.K.: Decreased serum salicylate concentrations in children with rheumatic fever treated with antacid. New England Journal of Medicine 293: 323–325 (1975).
Levy, G.; Baliah, T. and Procknal, J.A.: Effect of renal transplantation on protein binding of drugs in serum of donor and recipient. Clinical Pharmacology and Therapeutics 20: 512–516 (1976).
Lieberman, S.V. and Wood, J.M.: Aspirin formulation and absorption rate. II. Influence on serum levels of tablets, antiacids and solutions. Journal of Pharmaceutical Sciences 53: 1492–1495 (1964).
Levy, G.; Procknal, J.A.; Olufs, B.A.R. and Pachman, L.M.: Relationship between serum salicylate concentration and free or total salicylate concentration in serum of children with juvenile rheumatoid arthritis. Clinical Pharmacology and Therapeutics 27: 619–627 (1980).
Macpherson, C.R.; Milne, M.D. and Evans, B.M.: The excretion of salicylate. British Journal of Pharmacology 10: 484–489 (1955).
Mäkelä, A.-L.; Yrjänä, T. and Haapasaari, J.: Dosage of salicylates for children with juvenile rheumatoid arthritis. Scandinavian Journal of Rheumatology 4, 250–252 (1975).
Mäkelä, A.L.; Yrjänä, T. and Mattila, M.: Dosage of salicylate for children with juvenile rheumatoid arthritis. Acta Paediatrica Scandinavica 68: 423–430 (1979).
Miller, R.L. and Melmon, K.L.: Inflammatory disorders; in Morrelli and Melmon (Eds.) Clinical Pharmacology, pp.382–417 (MacMillan, New York 1972).
Miller, R.R.: Deafness due to plain and long acting aspirin tablets. Journal Clinical Pharmacology 18: 468–471 (1978).
Mitchell, I.: ‘Therapeutic’ salicylate poisoning in children. British Medical Journal 1: 1081 (1979).
Mongan, E.; Kelly, P.; Nies, K.; Porter, W.W. and Paulus, H.E.: Tinnitus as an indication of therapeutic serum salicylate levels. Journal of American Medical Association 226: 142–145 (1973).
Muller, F.O.; Thundt, H.K.L. and Muller, D.G.: Pharmacokinetic and pharmacodynamic implications of long-term administration of non steroidal antiinflammatory agents. International Journal of Clinical Pharmacology 15: 397 (1977).
Muni, I.A.; Leeling, J.L.; Helms, R.J.; Johnson, N.; Bare, J.J. and Phillips, B.M.: Improved colorimetric determination of aspirin and salicylic acid concentrations in human plasma. Journal of Pharmaceutical Sciences 67: 289–291 (1978).
Nikelly, J.G.: Gas chromatographic determination of acetylsalicylic acid in the blood. Analytical Chemistry 36: 2248–2250 (1964).
Nowak, M.M., Brundhofer, B. and Gibaldi, M.: Rectal absorption from aspirin suppositories in children and adults. Pediatrics 54: 23–26 (1974).
O’Gorman, T. and Koff, R.S.: Salicylate hepatitis. Gastroenterology 72: 726–8 (1977).
Pachman et al.: Pharmacokinetic monitoring of salicylate therapy in children with juvenile rheumatoid arthritis. Arthritis and Rheumatism 22: 826–831 (1979).
Paulus, H.E. and Whitehouse, M.W.: Nonsteroid anti-inflammatory agents. Annual Review of Pharmacology 13: 107–125 (1973).
Paulus, H.E.; Siegel, M.; Mongan, E.; Okun, R. and Calabro, J.J.: Variations of serum concentrations and half life of salicylate in patients with rheumatoid arthritis. Arthritis and Rheumatism 14: 527–532 (1971).
Peng, G.W.; Gadalla, M.A.F.; Smith, V.; Peng, A. and Chiou, W.L.: Simple and rapid high-pressure liquid chromatographic simultaneous determination of aspirin, salicylic acid, and salicyluric acid in plasma. Journal of Pharmaceutical Sciences 67: 710–712 (1978).
Pierce, A.W. Jr.: Salicylate poisoning. Pediatrics 54: 342–347 (1974).
Rance, M.J.; Jordan, B.J. and Nichols, J.D.: A simultaneous determination of acetylsalicylic acid, salicylic acid and salicylamide in plasma by gas liquid chromatography. Journal of Pharmacy and Pharmacology 27: 425–429 (1975).
Reynolds, R.C. and Cluff, L.E.: Interaction of serum and sodium salicylate: changes during acute infection and the influence on pharmacological activity. Bulletin of Johns Hopkins Hospital 107: 278–290 (1960).
Richens, A. and Warrington, S.: When should plasma drug levels be monitored? Drugs 17: 488–500 (1979).
Routh, J.I.; Shane, N.A.; Arredondo, F.G. and Paul, W.D.: Method for the determination of acetylsalicylic acid in the blood. Clinical Chemistry 13: 734–743 (1967).
Rowland, M. and Riegelman, S.: Pharmacokinetics of acetylsalicylic acid and salicylic acid after intravenous administrations in man. Journal of Pharmaceutical Sciences 57: 1313–1319 (1968).
Rowland, M.; Riegelman, S.; Harris, P.A.; Sholkoff, S.D. and Eyring, E.J.: Kinetics of acetylsalicylic acid disposition in man. Nature 215: 413–414 (1967).
Rowland, M.; Riegelman, S.; Harris, P.A. and Sholkoff, S.D.: Absorption kinetics of aspirin in man following oral administration of an aqueous solution. Journal of Pharmaceutical Sciences 61: 379–385 (1972).
Rumble, R.H.; Brooks, P.M. and Roberts, M.S.: Interaction between levamisole and aspirin in man. British Journal of Clinical Pharmacy 7: 631–633 (1979).
Rumble, R.H.; Brooks, P.M. and Robertz, M.S.: Metabolism of salicylate during chronic aspirin therapy. British Journal of Clinical Pharmacology 9: 41–45 (1980).
Salem, S.A.M. and Stevenson, I.H.: Absorption kinetics of aspirin and quinine in elderly subjects. British Journal of Clinical Pharmacology 4: 397P (1977).
Schachter, D. and Manis, J.G.: Salicylate and salicyl conjugates: fluorimetric estimation, biosynthesis and renal excretion in man. Journal of Clinical Investigation 37: 800–807 (1958).
Sholkoff, S.D.; Eyring, E.J.; Rowland, M. and Riegelman, S.: Plasma and synovial fluid concentrations of acetylsalicylic acid in patients with rheumatoid arthritis. Arthritis and Rheumatism 10: 348–351 (1967).
Smith, M.J.M.: Plasma-salicylate concentrations after small doses of acetylsalicylic acid. Journal of Pharmacy and Pharmacology 3: 409–414 (1951).
Smith, P.K.; Gleason, H.L.; Stoll, C.G. and Ogorzalek, S.: Studies on the pharmacology of salicylates. Journal of Pharmacology and Experimental Therapeutics 87: 237–255 (1946).
Smyth, C.J. and Bravo, J.F.: Antirheumatic drugs: clinical pharmacological and therapeutic aspects. Drugs 10: 394–425 (1975).
Soren, A.: Kinetics of salicylates in blood and joint fluids. Journal of Clinical Pharmacology 15: 173–177 (1975).
Spector, R.; Korkin, D.T. and Lorenzo, A.V.: A rapid method for the determination of salicylate binding by the use of ultrafilters. Journal of Pharmacy and Pharmacology 24: 786–789 (1972).
Stevenson, G.W.: Rapid ultraviolet spectrophotometric determination of salicylate in blood. Analytical Chemistry 32: 1522–1525 (1960).
Stevenson, R.L. and Burtis, C.A.: The analysis of aspirin and related compounds by liquid chromatography. Journal of Chromatography 61: 253–261 (1971).
Talberl, R.L.; Ludden, T.M. and West, R.E.: Rapid establishment of therapeutic serum concentrations of salicylates. Journal of Clinical Pharmacology 19: 108–112 (1979).
Talbert, R.L.; Ludden, T.M.; Littlefield, L.C. and Reed, W.E.: Development of a loading regimen for aspirin. Current Therapeutic Research 27: 584–594 (1980).
Thomas, B.H.; Solomonraj, G. and Coldwell, B.B.: The estimation of acetylsalicylic acid and salicylate in biological fluids by gas-liquid chromatography. Journal of Pharmacy and Pharmacology 25: 201–204 (1973).
Tognoni, G.; Bellantuono, C.; Bonati, M.; D’Incalci, M.; Gerna, M.; Latini, R.; Mandelli, M.; Porro, M.G. and Riva, E.: Clinical relevance of pharmacokinetics. Clinical Pharmacokinetics 5: 105–136 (1980).
Tognoni, G.; Lakin, R. and Jusko, W.W. (Eds). Frontiers in Therapeutic Drug Monitoring (Raven Press, 1980).
Trinder, P.: Rapid determination of salicylate in biological fluids. Biochemical Journal 57: 301–303 (1954).
Tsuchiya, T. and Levy, G.: Relationship between dose and plateau levels of drugs eliminated by parallel first-order and capacity-limited kinetics. Journal of Pharmaceutical Sciences 61: 541–544 (1972a).
Tsuchiya, T. and Levy, C.: Biotransformation of salicylic acid to its acyl and phenolic glucuronides in man. Journal of Pharmaceutical Sciences 61: 800–801 (1972b).
Vesell, E.S.: Relationship between drug distribution and therapeutic effects in man. Annual Review of Pharmacology 14: 249–270 (1974).
Walter, L.J.; Biggs, D.F. and Coutts, R.T.: Simultaneous GLC estimation of salicylic acid and aspirin in plasma. Journal of Pharmaceutical Sciences 63: 1754–1758 (1974).
Watson, J.R.; Crescuolo, P. and Fumi Matsui: Rapid simultaneous determination of salicylic acid and aspirin by GC/I: analysis of synthetic aspirin-salicylic acid mixtures and of single-component aspirin tablets. Journal of Pharmaceutical Sciences 60: 454–458 (1971).
Wiegand, R.G. and Sanders, P.C.: Calculation of kinetic constants from blood levels of drugs. Journal of Pharmacology and Experimental Therapeutics 146: 271–275 (1964).
Williams, L.A.; Linn, R.A. and Zak, B.: Differential ultraviolet spectrophotometric determination of serum salicylates. Journal of Laboratory and Clinical Medicine 53: 156–162 (1959).
Wilson, J.T.; Howell, R.L.; Holladay, M.W.; Brilis, G.M.; Chrastil, J.; Watson, J.T. and Taber, D.F.: Gentisuric acid: metabolic formation in animals and identification as a metabolite of aspirin in man. Clinical Pharmacology and Therapeutics 23: 635–643 (1978).
Wolfe, J.D.; Metzger, A.L. and Goldstein, R.C.: Aspirin hepatitis. Annals of Internal Medicine 80: 74–76 (1974).
Wosilait, W.D.: Theoretical analysis of the binding of salicylate by human serum albumin: The relationship between free and bound drug and therapeutic levels. European Journal of Clinical Pharmacology 9: 285–290 (1976).
Wurster, D.E. and Kramer, S.F.: Investigation of some factors influencing percutaneous absorption. Journal of Pharmaceutical Sciences 50: 288–293 (1961).
Yacobi, A. and Levy, G.: Intraindividual relationship between serum protein binding of drug in normal human subjects, patients with impaired renal function, and rats. Journal of Pharmaceutical Sciences 66: 1285–1288 (1977).
Zimmerman, H.J.: Editorial: Aspirin-induced hepatic injury. Annals of Internal Medicine 80: 103–105 (1974).